CK Life Sciences International Holdings Inc

00775

Company Profile

  • Business description

    CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.

  • Contact

    2 Dai Fu Street
    Tai Po Industrial Estate
    Tai Po
    Hong Kong
    HKG

    T: +852 21261212

    https://www.ck-lifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    1,920

Stocks News & Analysis

stocks

Undervalued tech share oversold on AI fears

Has the market overlooked this ASX tech share?
stocks

Margins have bottomed for ASX listed consumer goods company

Impact of tariffs have been priced in.
stocks

SpaceX rally continues, expanding sky-high valuations

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,031.209.400.10%
CAC 408,400.1121.03-0.25%
DAX 4025,151.48165.660.66%
Dow JONES (US)51,745.30180.600.35%
FTSE 10010,437.8574.580.72%
HKSE23,768.52156.29-0.65%
NASDAQ26,216.82301.11-1.14%
Nikkei 22572,353.961,103.901.55%
NZX 50 Index13,446.0549.58-0.37%
S&P 5007,473.9826.60-0.35%
S&P/ASX 2008,816.1014.200.16%
SSE Composite Index4,163.1072.621.78%

Market Movers